EN DE
Watch Crawford & Company for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Crawford & Company (CRD-B) fair value: what the stock is really worth

As of Nov 16, 2026: fair value (intrinsic value) of Crawford & Company stock $4.43, price $11.35, that is 61.0% below the price, quality 60 out of 100. Rating: strongly overvalued. Calculated from audited financials with 4 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Financial Services US

CC Crawford & Company logo Broad data Nov 17, 2026

Crawford & Company

CRD-B · US

Far too expensive (fair value 61% below the price), but solid company and rising price: meets 2 of 3 rules.

Get notified free when this changes
Quality 60/100 
Rising price (uptrend) 
Generates free cash flow 
2.7% dividend yield · Well covered
Recent news very positive 
Broad data 
Mixed Growth (revenue 5y +5.3 %/yr in USD) 
Thin margins · 2.1% net margin (TTM) 
Moderate debt 
Insiders sold $785,279 (6M) 
Changed on Nov 12: $3.48 → $4.43 
Fair value $4.43 · Strongly overvalued 
Trails peers (4/14) 
Narrow moat 42/100
Watch Crawford & Company for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$13.10 $4.52 Fair Value $4.43 Aug 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 17, 2026.

How to read this chart

60‑month range $4.52 – $13.10 · fair‑value band $3.30 – $5.49 · the $11.35 price screens above the $4.43 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. As of Nov 17, 2026.

Follow Crawford & in your weekly email

Every Wednesday you see whether Crawford & is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Crawford & Company provides claims management and outsourcing solutions for carriers, brokers, and corporations in the United States, the United Kingdom, Europe, Canada, Australia, Asia, and Latin America.

Show moreShow less

The company provides claims management services to insurance carriers and self-insured entities risk, including property, public liability, automobile liability, and marine insurance; claims management and adjusting services to insurance carriers and self-insured entities from property and casualty insurance company markets; and field investigation and the evaluation and resolution of property and casualty insurance claims.

It also offers claims management services, including workers' compensation, liability, and property; death and dismemberment, business travel, life, disability, critical illness, and credit protection claims programs; short and long term disability, family medical leave act, Americans with disabilities act, and state leave claims; legal services, risk management information, and consultative analytical services; loss mitigation services, such as medical bill review, medical case management and vocational rehabilitation; risk management information services; and administration of loss funds established to pay claims.

In addition, the company provides managed repair service and outsourced contractor management to national and regional personal and commercial insurance carriers; services to insurance companies on losses caused by all types of natural disasters comprising fires, hailstorms, hurricanes, earthquakes, floods, as well as man-made disasters, such as oil spills, chemical releases, and explosions; staff augmentation that provides temporary staffing resources; and outsourced subrogation claims management, recovery, and consultative services for the property and casualty insurance industry.

Crawford & Company was founded in 1941 and is headquartered in Atlanta, Georgia.

Stock analysis

Crawford & Company (CRD-B) currently trades at $11.35, while our model-based Fair Value estimate is $4.43, 61% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the Multiples group reads highest at a median of $5.21 per share, and 0 of the 4 models we run sit above the $11.35 price.

Bear case: the Economic Profit group reads lowest at $3.48, and 4 of the 4 models stay below the price. Data coverage for this calculation is high.

Scenario range: $3.30 (bear) to $5.49 (bull), the price of $11.35 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 60/100 (solid quality), in the Financial Services sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Crawford & Company reported revenue of $1.3B in FY2025 versus $1.1B in FY2021, a compound +3.6%/yr. Reported net income was $19.6M in FY2025, compounding −10.6%/yr from FY2021.

Key figures

Market cap $556M Small · P/E ratio 21.2 · P/S ratio 0.44 · EPS (TTM) $0.5300 · Dividend yield 2.7% · Net margin 2.1% · Return on equity 14.1% · Return on assets (EBIT) 7.9% (5-year average).

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 42 out of 100 (medium confidence).

What moves the price

The share trades about 13% below its 52-week high and 28% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Financial Services peers we cover trades at −52% fair-value upside, at −61%, CRD-B screens richer than that median.

Fair Value models

Bear $3.30 Fair Value $4.43 Bull $5.49
Price $11.35 · Downside -61.0%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 11 months old). Earnings retained since then ($0.1979 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
Residual Income $3.13 $3.48 $4.20 76
Gordon GGM $3.30 $4.43 $5.49 69
DDM Multi-Stage $3.30 $4.43 $5.64 67
All 4 models by family
Dividend Discount
Gordon GGM $3.30 $4.43 $5.49 69
DDM Multi-Stage $3.30 $4.43 $5.64 67
Multiples
P/E Multiple $3.91 $5.21 $6.51 63
Economic Profit
Residual Income $3.13 $3.48 $4.20 76

Open the full fair value analysis →

Quality Score breakdown

Overall quality 60/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 55
How much profit the company makes from its sales and capital
Quality Growth 39
Are margins and returns getting better?
Cashflow 69
Do the profits arrive as real cash?
Financial strength 31
Debt, balance sheet and risk of trouble
Investment 81
Does it invest with discipline instead of growing at any price?
Low Volatility 62
How calm the share price moves, does not count
Price momentum 50
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 51
Distance to the 52-week high, does not count
New shares 94
Buys back shares or issues new ones?

Open the full quality analysis →

Insider trades

In the last 6 months, one officer or director sold shares worth $785,279 and none bought.

  • SaleAndrew John BartExecutive Vice President8× since May 18, 2026: 68,920 shares, avg. $11.39$785,279Nov 11, 2026
  • SaleJesse C Crawford10% owner1,000,000 shares at $12.81$12.8MAug 10, 2026
  • SaleTami E. StevensonSVP-GC & Corp Secy26,282 shares at $9.58$251,777May 8, 2026
  • SaleRohit VermaCEO & President, Director125,414 shares at $11.00$1.4MDec 11, 2025

Plus 4 other filings such as grants, option exercises or tax withholding. They are not market purchases or sales.

Sales are often planned (taxes, diversification, 10b5-1 plans). Purchases with their own money are seen as the stronger sign. For information only: not part of the quality score or Fair Value.

Source: SEC Form 4, as of Nov 16, 2026. All filings at the SEC ↗

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 64/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
−2.0%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+2.2%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+5.3%
Start year 2020 (pandemic). Over 10 years: +0.6% a year
Revenue growth 40 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+4.6%
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
−3.1%
Earnings growth per share plus dividend.
Earnings per share, growth per year−5.8%
Dividend (yield on the price)2.7%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−5.8% vs −4.5%, steady
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.6% → 6%
Pace: the 5-year rate starts in 2020 (pandemic)

Growth Forecast

Little optimism in the price
The price assumes less growth than the company has delivered so far and less than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−7.9%
The company could shrink this much every year for the next five years and today's price would still be justified.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
−0.3%
Yearly sales growth analysts expect, extended to five years.
After inflation (USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about −10.0% a year for the price and −2.6% for the forecasts.
Forecast 2026 (sales)−0.7%
Forecast 2027 (sales)−0.7%
Projected 2028 (sales)−0.4%
Projected 2029 (sales)0.0%
Projected 2030 (sales)+0.3%

CRD-B screens overvalued: fair value 61% below the price. Compare with Marsh & McLennan Companies, Inc →

Earlier news

News mood ⓘNews mood, the average tone of recent news (90 articles), rated against how stocks are usually covered. 🚀 Hype = unusually upbeat · 🙂 Positive = above average · 😐 Neutral = typical · 🙁 Negative = below average · 😨 Very negative = unusually downbeat. It reflects the tone of coverage, not our valuation. Hype
Recent news coverage is unusually upbeat, far more positive than stocks are typically covered.

Compare Crawford & Company with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Insurance Brokers · 32 stocks

Beats the industry median on 4/14 measures
Overall it trails its industry peers.
Valuation
Quality Score 60 · Below median
Fair Value upside −61.0% · Below median
Profitability
Return on equity (12 months) 14.1% · Below median
Return on assets 2.6% · Bottom 25%
Net margin (12 months) 2.1% · Bottom 25%
Operating margin (12 months) 7.8% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) −0.2% · Below median
Dividend yield (12 months) 2.7% · Below median
Balance sheet
Debt / equity 0.87× · Highest 25%

Valuation Multiplesvs Insurance Brokers median · lower = cheaper

P/E (12 months) 21.2× · Pricier than median
P/B 3.21× · book value is mostly intangible assets ⓘGoodwill and other intangible assets (such as prices paid for past acquisitions, brands, licences or film and series rights) are larger than the equity. So we do not rank this P/B against the peer group.
P/S (12 months) 0.44× · Cheapest 25%
Price / free cash flow (fiscal year) 5.9× · Cheapest 25%
EV/EBITDA 7.5× · Cheaper than median
PEG 0.90× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 0
FUTURE (revenue growth)0 · sector 32
PAST (return on equity)56 · sector 64
HEALTH (low debt)57 · sector 74
DIVIDEND (yield)54 · sector 66

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Insurance Brokers stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Willis Towers Watson Public Limited WTW $338.13 $226.26 −33% vs CRD-B
Aon plc AON $343.12 $216.63 −37% vs CRD-B
Steadfast Group SDF A$5.78 A$3.15 −46% vs CRD-B
Marsh & McLennan Companies, Inc MRSH $209.88 $113.73 −46% vs CRD-B
Brown & Brown, Inc BRO $73.51 $35.14 −52% vs CRD-B
CorVel Corporation CRVL $87.34 $39.94 −54% vs CRD-B
Erie Indemnity Company ERIE $275.91 $113.19 −59% vs CRD-B
Arthur J. Gallagher & Co AJG $287.00 $75.74 −74% vs CRD-B
PB Fintech Limited POLICYBZR ₹1,081 ₹137.52 −87% vs CRD-B
Ryan Specialty Holdings RYAN $47.86 $5.30 −89% vs CRD-B

Explore undervalued stocks

More undervalued Financial Services stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Crawford & Company: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Crawford & Company Fair Value". https://www.fairvalue-calculator.com/stock/CRD-B

Frequently asked questions

Is Crawford & Company (CRD-B) overvalued or undervalued?
As of Nov 17, 2026, our model estimates a fair value of $4.43 versus a price of $11.35, about 61% lower (overvalued).
What is the fair value of CRD-B?
Our model-based fair value for Crawford & Company is $4.43 (as of Nov 17, 2026), built from audited fundamentals. The current price: $11.35.
What is the quality score of CRD-B?
Crawford & Company has a Quality Score of 60/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Crawford & Company (CRD-B)?
Our model-based price target is the fair value of $4.43 (as of Nov 17, 2026) from 4 valuation models. Cautious scenario $3.30, optimistic scenario $5.49. It is a calculation from audited fundamentals, not an analyst target.
What is the Crawford & Company stock forecast for 2026?
Our models put fair value at $4.43, about 61% lower versus a price of $11.35 (overvalued). Cautious scenario $3.30, optimistic scenario $5.49. The calculation is refreshed regularly with new filings.
What is the revenue of Crawford & Company (CRD-B)?
Crawford & Company reported trailing-twelve-month revenue of about $1.3B (latest available figure, as of Nov 17, 2026).
Does Crawford & Company pay a dividend?
Crawford & Company currently shows a dividend yield of 2.69% relative to its recent price (as of Nov 17, 2026).
How much is the dividend of Crawford & Company (CRD-B) and when is the ex-dividend date?
Crawford & Company pays a dividend of $0.305 per share a year, a dividend yield of 2.7%. The next ex-dividend date is Nov 18, 2026, with payment on Dec 4, 2026. A dividend has been paid every year since 2011. The payout ratio is 24.8% of earnings (on adjusted earnings, reported 57.5%). Free cash flow covers the dividend 16.45 times. Our assessment: Well covered. A low payout and the dividend is fully funded by free cash flow, a comfortable, sustainable dividend.
What growth is priced into Crawford & Company (CRD-B)?
Today's price is already fair in a discounted-cash-flow model if free cash flow at Crawford & Company shrinks by 7.9 % per year for five years (discount rate 10.3 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew 5.3 % per year. As of Nov 17, 2026.
What discount rate (WACC) does the fair value of CRD-B use?
Our models discount Crawford & Company at 10.3 %: a base by market capitalisation (small), damped by beta 0.66, country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Crawford & Company that is -7.9 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (10.3 %) and the same formula as our fair value.
How much growth has Crawford & Company (CRD-B) delivered so far?
Over the past 5 years revenue at Crawford & Company grew 5.3 % a year. The price currently implies free-cash-flow growth of -7.9 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Crawford & Company (CRD-B) growing?
The median revenue growth in the sector is +9.7 % a year. That is the yardstick for the growth priced into Crawford & Company (-7.9 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Crawford & Company (CRD-B)?
The free-cash-flow yield on the price is 17.06 %: that much free cash flow Crawford & Company produces per unit of market value. When it exceeds the discount rate of our models (10.3 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Crawford & Company (CRD-B)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Crawford & Company it is $4.43 per share (as of Nov 17, 2026), against a price of $11.35. It is the blended result of 4 valuation models in 3 families (Dividend Discount, Multiples, Economic Profit).
Is Crawford & Company stock overvalued or undervalued in 2026?
As of Nov 17, 2026, CRD-B trades above its calculated fair value: price $11.35, fair value $4.43, a gap of about −61% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of CRD-B?
No. The price is what the market pays today ($11.35); the fair value is what the company's own numbers justify ($4.43). For Crawford & Company the two are $6.92 per share apart. That gap is exactly why we show both numbers side by side.
How much is Crawford & Company worth?
The market values Crawford & Company at about $556M (market capitalisation, as of Nov 17, 2026). Per share that is $11.35; our models calculate a fair value of $4.43 per share.
What do the bullish and bearish scenarios say about CRD-B?
Our models span a range for Crawford & Company: cautious scenario $3.30, base $4.43, optimistic $5.49 per share (as of Nov 17, 2026, price $11.35). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of CRD-B?
Crawford & Company trades at a price-to-earnings ratio of 21.2 (as of Nov 17, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $4.43 is built from several models across several years. Excluding one-off items of fiscal year 2025 it is 12.5 (reported for FY2025: 28.9). Median P/E at fiscal year-end, 9 fiscal years (2016 to 2025), reported earnings, FY2025 ex one-offs: 18.5. Other multiples: PEG 0.9, P/B 3.2, P/S 0.4, EV/EBITDA 7.5.
What is the PEG ratio of CRD-B?
The PEG ratio of Crawford & Company is 0.90 (P/E divided by earnings growth, as of Nov 17, 2026). That is below 1, so growth is priced more cheaply than the earnings multiple alone suggests.
How solid is the balance sheet of Crawford & Company (CRD-B)?
Balance-sheet figures for Crawford & Company (as of Nov 17, 2026): return on equity 14.1%, debt of 0.87 per unit of equity. They feed the Quality Score of 60/100, which measures business quality independently of the share price.
How far is CRD-B from its 52-week high?
Crawford & Company trades at $11.35, about 13% below its 52-week high of $13.10 and 28% above the low of $8.90 (as of Nov 16, 2026). Distance from the high says nothing about value: that is what the fair value of $4.43 is for.
Which stocks are comparable to Crawford & Company?
From the same area (Financial Services) we also value Marsh & McLennan Companies, Inc, Arthur J. Gallagher & Co, Aon plc, Willis Towers Watson Public Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Crawford & Company stock attractive at the current price?
The data as of Nov 17, 2026: price $11.35, calculated fair value $4.43 (−61%), Quality Score 60/100, from 4 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of CRD-B calculated?
We run Crawford & Company through 4 models from 3 families: Dividend Discount, Multiples, Economic Profit. Every model gets the same audited fundamentals; the fair value of $4.43 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.6% above its aggregate fair value. Crawford & Company itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Crawford & Company (CRD-B)?
The closing price on Nov 16, 2026 was $11.35. Our model-based fair value is $4.43, about 61% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Crawford & Company right now?
The price sits above even our optimistic bull case ($5.49). The favourable scenario is already priced in. Solid but not exceptional quality (60/100) and above fair value, neither a clear bargain nor a standout compounder. For a financial, book-value and earnings-based methods matter more than a cash-flow DCF, which fits banks and insurers poorly.
Where does the earnings growth of Crawford & Company (CRD-B) come from?
Earnings per share at Crawford & Company fell 2.1 % a year from 2014 to 2025. Broken into its drivers: revenue per share +2.0 %, EBIT margin −1.2 %, tax rate +1.4 %, residual (interest, one-offs) −4.1 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.

Key figures of Crawford & Company

How large is the market capitalisation of Crawford & Company (CRD-B)?
The market capitalisation of Crawford & Company is $556M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Crawford & Company (CRD-B)?
The price-to-sales ratio of Crawford & Company is 0.44 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Crawford & Company (CRD-B)?
Earnings per share at Crawford & Company are $0.5300 (price ÷ EPS = P/E 21.2). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Crawford & Company (CRD-B)?
The dividend yield of Crawford & Company is 2.7% (payout 24.8%, on adjusted earnings, reported 57.5%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Crawford & Company (CRD-B)?
The net margin of Crawford & Company is 2.1% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Crawford & Company (CRD-B)?
The return on equity (ROE) of Crawford & Company is 14.1% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Crawford & Company (CRD-B)?
On an EBIT basis the return on assets of Crawford & Company is 7.9% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Crawford & Company (CRD-B)?
The operating margin of Crawford & Company is 7.8% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Crawford & Company (CRD-B)?
Revenue at Crawford & Company is down 0.2% versus a year earlier (3y avg +2.2%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Crawford & Company (CRD-B)?
Earnings per share at Crawford & Company are growing 24.8% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Crawford & Company (CRD-B) carry?
The net debt of Crawford & Company is $206M (fiscal year 2025, ≈ 2.2 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Crawford & Company in the live analysis

One click puts Crawford & Company on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.